HakanOralMD

Cardiac Electrophysiology

Professor, Internal Medicine, University of Michigan Medical School

Overview of Dr. Oral

Hakan Oral, MD, is a cardiology specialist based in Ann Arbor, MI, with a subspecialty in cardiac electrophysiology. He completed his fellowship in Clinical Cardiac Electrophysiology at the University of Michigan and a residency in Internal Medicine at Baylor College of Medicine. Dr. Oral has expertise in catheter ablation of atrial fibrillation, supraventricular arrhythmias and ventricular arrhythmias, implantation of cardiac implantable electronic devices, electrocardiography, electrophysiology, and the management of atrial fibrillation and flutter. His research contributions include significant publications on catheter ablation and cardiac arrhythmias, and he has been involved in clinical trials exploring adjunctive therapies for atrial fibrillation. Dr. Oral's professional recognition includes a CMS Meaningful Use Stage 1 Certification from Epic Systems and fellowship with the American College of Cardiology.

Office
1500 East Medical Center Dr
3rd Floor Cardiovascular Center
Ann Arbor, MI 48109
Book by Phone+1(877) 846-2460

Education & Training

University of MichiganFellowship, Clinical Cardiac Electrophysiology, 1999 - 2000
Baylor College of MedicineResidency, Internal Medicine, 1992 - 1996
Hacettepe University FOMClass of 1990

Certifications & Licensure

MI State Medical License 1996 - 2027
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Clinical Cardiac Electrophysiology

Awards, Honors, & Recognition

Fellow (FHRS) Heart Rhythm Society
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Fellow (FACC) American College of Cardiology

Clinical Trials

Radiofrequency Catheter Ablation for Chronic Atrial Fibrillation Start of enrollment: 2002 Nov 01
Completed
Not Applicable
Effects of Fish Oil on Post Ablation Arrhythmias Start of enrollment: 2008 Nov 01
Terminated
Phase 4
Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation Start of enrollment: 2017 Mar 23
Completed
Phase 4
Metformin as an Adjunctive Therapy to Catheter Ablation in Atrial Fibrillation Start of enrollment: 2021 Jan 19
ACTIVE_NOT_RECRUITING
PHASE4
Join now to see all

Publications & Presentations

PubMed

Catheter Ablation of Parahisian Premature Ventricular Complexes From the Right Sinus of Valsalva.
Michael Ghannam, Jamie Simpson, Mohamed Al-Sadawi, Amrish Deshmukh, Jackson J Liang
Journal of Cardiovascular Electrophysiology. 2024-12-08
Dofetilide for the treatment of premature ventricular complexes and ventricular tachycardia in patients with structural heart disease.
Amrish Deshmukh, Miki Yokokawa, Daniel McBride, Jamie Simpson, Andrew Chou
Journal of Cardiovascular Electrophysiology. 2024-12-01
Non-invasive fibrosis markers are useful in predicting the presence of varices in compensated cirrhosis and variceal bleeding in decompensated cirrhosis.
Hakan Oral, Bengi Ozturk, Taylan Kav, Onur Keskin
Internal and Emergency Medicine. 2024-10-10

Lectures

New Horizons in Atrial Fibrillation
American Heart Association, Scientific Sessions 2011, Orlando, Florida, USA
New Horizons in Atrial Fibrillation
Scientific Sessions 2011, Orlando, Florida, USA

Press Mentions

Recycled Pacemakers Function as Well as New Devices, International Study SuggestsNovember 17th, 2024

Professional Memberships

American College of Cardiology - ACC
Fellow
Endocrine Society - ENDO
Member

Insurance Accepted

Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Cofinity PPO
First Health PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment